$117.690
+2.919 (+2.48%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KYMR por análisis de gráficos similares
Alphio's KYMR stock price prediction model matches the current Kymera Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $116.48 (-0.93%). The 1-week path is $118.29 (+0.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Kymera Therapeutics Inc?
Kymera Therapeutics Inc is a good buy right now, trading at $110.76 with a strong year-to-date change of +52.23% and a forward P/E of 0, indicating potential for future earnings growth. The upcoming Phase 2b BROADEN2 trial results for KT-621 are expected by the end of 2026, which could significantly impact the stock price. However, the main risk is the negative net income reported at -61,211,000 USD for Q2 2026, which highlights ongoing financial challenges.
KYMR cerró en $117.69 el Tuesday, tras subir +2.48%
Kymera Therapeutics Inc (KYMR) last closed at $117.5699997, gaining +2.38%. These facts feed the 1-day and 1-week KYMR price prediction above.
Factores de la previsión
Los factores de la previsión de Kymera Therapeutics Inc (KYMR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KYMR, ordenadas por similitud.
Análisis de estacionalidad de KYMR
Historically the probability of a positive October return for KYMR is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de KYMR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $28.11 | $29.73 | $33.03 | -74.71% |
| Nov 2026 | $27.33 | $31.25 | $33.15 | -73.42% |
| Dec 2026 | $19.49 | $26.59 | $33.21 | -77.39% |
En 2026, se proyecta que Kymera Therapeutics Inc (KYMR) oscile entre $19.49 y $33.21.
Previsión mensual de Kymera Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Kymera Therapeutics Inc promedie $29.73, con un mínimo de $28.11 y un máximo de $33.03.
En Nov de 2026, se proyecta que Kymera Therapeutics Inc promedie $31.25, con un mínimo de $27.33 y un máximo de $33.15.
En Dec de 2026, se proyecta que Kymera Therapeutics Inc promedie $26.59, con un mínimo de $19.49 y un máximo de $33.21.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.